Qu, K., Li, M., Yu, P., Palotie, A., Pressman, A., Belin, A. C., . . . Lessel, D. (2024). HMG-CoA reductase is a potential therapeutic target for migraine: A mendelian randomization study. Scientific Reports, 14(1), 1. https://doi.org/10.1038/s41598-024-61628-9
Chicago Style (17th ed.) CitationQu, Kang, et al. "HMG-CoA Reductase Is a Potential Therapeutic Target for Migraine: A Mendelian Randomization Study." Scientific Reports 14, no. 1 (2024): 1. https://doi.org/10.1038/s41598-024-61628-9.
MLA (9th ed.) CitationQu, Kang, et al. "HMG-CoA Reductase Is a Potential Therapeutic Target for Migraine: A Mendelian Randomization Study." Scientific Reports, vol. 14, no. 1, 2024, p. 1, https://doi.org/10.1038/s41598-024-61628-9.
Warning: These citations may not always be 100% accurate.